The first implementation stage of UnCovid —a new rapid molecular test to detect COVID-19 cases developed by researchers at Peruvian University of Applied Sciences (UPC)— has been successfully completed.
Biologist Vanessa Adaui, leader of the project, explained that
this low-cost rapid molecular test uses a fluorescent detection system, that is, a sample is defined as positive for SARS-CoV-2 if fluorescence is observed, and negative if no fluorescence signal is detected.
"The result can be easily visualized using a transilluminator, equipment used by the principal laboratories —in Lima and some provinces— that rely on the minimum equipment for molecular biology techniques," said Adaui, Doctor of Biomedical Sciences from the
University of Antwerp (Belgium).
According to the researcher, this molecular test detects coronavirus presence in around 30 minutes, counted from the moment the virus genetic material —previously amplified by RT-PCR— is analyzed.
In addition, it will be more affordable than other tests currently in use.
"Likewise, UnCovid's biological components (enzymes, guide RNA molecules) can be produced locally, and we have managed to standardize the process. This makes UnCovid a molecular test that is less dependent on the international supply chain (reagents, chemical inputs, instruments), which is saturated by the health crisis," she added.
(EN) MFA/SPV/RMB/MVB
Publicado: 10/7/2020